Seegnal (SEGN.V) has begun its first pilot program in the U.S., with a long-term care provider there.
Seegnal, a healthcare technology provider working to reduce medication risks, expects the pilot program to last between eight and 12 weeks, from when the data is received. An evaluation period may follow.
"Initiating this pilot is an important step in executing on our U.S. commercial strategy," said Elad Bibi-Aviv, chief executive officer. "Long-term care is a setting where medication complexity, polypharmacy, and the need for individualized prescribing decisions converge. These are areas where our platform was designed to add value."